# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# T A B L E O F C O N T E N T S

|ABSTRACT|1|
|---|---|
|PLAIN LANGUAGE SUMMARY|2|
|SUMMARY OF FINDINGS|4|
|BACKGROUND|10|
|OBJECTIVES|11|
|METHODS|11|
|RESULTS|14|
|Figure 1|15|
|Figure 2|19|
|Figure 3|21|
|Figure 4|21|
|Figure 5|22|
|Figure 6|23|
|DISCUSSION|25|
|AUTHORS' CONCLUSIONS|27|
|ACKNOWLEDGEMENTS|28|
|REFERENCES|29|
|CHARACTERISTICS OF STUDIES|39|
|DATA AND ANALYSES|96|
|Analysis 1.1. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 1: Induction of clinical remission in UC at longest follow-up|99|
|Analysis 1.2. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 2: Induction of clinical remission in UC at 8 weeks|100|
|Analysis 1.3. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 3: Induction of clinical remission in UC at 12 weeks|100|
|Analysis 1.4. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 4: Induction of clinical remission in UC at longest follow-up: subgroup analysis by route of administration|101|
|Analysis 1.5. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 5: Induction of clinical remission in UC at longest follow-up: subgroup analysis by type of donor|102|
|Analysis 1.6. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 6: Induction of clinical remission in UC at longest follow-up: subgroup analysis by age|103|
|Analysis 1.7. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 7: Induction of clinical remission in UC at longest follow-up: subgroup analysis by frequency of FMT|104|
|Analysis 1.8. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 8: Induction of clinical remission in UC at longest follow-up: sensitivity analysis using fixed-effect model|105|
|Analysis 1.9. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 9: Induction of clinical remission in UC at longest follow-up: sensitivity analysis for available cases|105|
|Analysis 1.10. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 10: Induction of clinical remission in UC at longest follow-up: composite of clinical score and endoscopic score|106|
|Analysis 1.11. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 11: Serious adverse events for induction of remission in UC|106|
|Analysis 1.12. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 12: Serious adverse events for induction of remission in UC: subgroup analysis by route of administration|107|
|Analysis 1.13. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 13: Serious adverse events for induction of remission in UC: subgroup analysis by type of donor|108|
|Analysis 1.14. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 14: Serious adverse events for induction of remission in UC: subgroup analysis by age|109|
|Analysis 1.15. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 15: Serious adverse events for induction of remission in UC: sensitivity analysis using fixed-effect model|110|
|Analysis 1.16. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 16: Serious adverse events for induction of remission in UC: sensitivity analysis for available cases| |

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright Â© 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.